Global Computer-Aided Drug Discovery Market Size, Share & Trends Analysis Report, By Type (Structure-Based Drug Design, Ligand-Based Drug Design, and Sequence-Based Approaches), By Therapeutic Area (Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, and Diabetes), By End-User (Pharmaceutical Companies, Biotechnology Companies, and Research Laboratories), Forecast Period (2022-2028) The global computer-aided drug discovery market is anticipated to grow at a CAGR of 11.5% during the forecast period. A rapid upsurge in busy lifestyles coupled with the consumption of an unhealthy diet has led to the prevalence of many diseases and disorders such as cancer, cardiovascular disease, and others. The rising pollution level led to an increase in respiratory diseases, and the rising prevalence of cancer is fueling the demand for drug discoveries across the globe and thereby driving the market growth. The computer-aided technology assists radiologists in identifying or diagnosing cancer, neurological, and cardiovascular disease, and is widely used among various end-user verticals such as healthcare, research centers, and diagnostic laboratories. This, in turn, is resulting an increasing number of computer-aided drug discovery activities. The global computer-aided drug discovery market is segmented based on type, therapeutic area, and end-user. Based on type, the market is bifurcated into structure-based drug design, ligand-based drug design, and sequence-based approaches. Based on the therapeutic area, the market is segmented into oncology, neurology, cardiovascular disease, respiratory disease, and diabetes. Based on end-user, the market is segmented into pharmaceutical companies, biotechnology companies, and research laboratories. Based on end-user, the pharmaceutical companies segment is projected to attain considerable growth during the forecast period. These companies are gaining traction in the market owing to rising R&D activities, production of biologics, as well as unpredictable growth in the biopharmaceutical industry. According to the Reserve Bank of India (RBI), the Indian pharmaceutical export market turnover was $24.4 billion in 2020-21, witnessing an 18.1% year-on-year growth. India’s domestic pharmaceutical market was valued at $41 billion in 2021 and is likely to grow to $65 billion by 2024 and further expected to reach $130 billion by 2030. Hence, an increase in the volume of the pharmaceutical industry coupled with the rising R&D practices consequently leads to higher growth of the pharmaceutical companies' segment. This results in the rising drug discovery activities in the country, which supports the growth of the market. Geographically, the global computer-aided drug discovery market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Asia-Pacific region is expected to witness potential growth during the forecast period. The major factor driving the growth of the computer-aided drug discovery market in the region includes well-established biotechnology and biopharmaceutical companies in the Asia-Pacific region, and an upsurge in the demand for advanced drug products for R&D and biologics production is anticipated to influence the market growth in the region. The major companies serving the global computer-aided drug discovery market include F-Hoffman-La Roche Ltd., Bayer AG, Charles River Laboratories International Inc., Laboratory Corporation of America Holdings (Labcorp), and Schrödinger, Inc. The market players are contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, and new product launches, to stay competitive in the market. For instance, in July 2022, Aurigene Discovery Technologies Ltd announced a collaboration with EQRx to accelerate the development of the drug in the areas of oncology and immune-inflammatory diseases and improve global access to innovative medicines. This agreement further validates Aurigene’s proven expertise in the discovery and preclinical development of novel therapeutics and moves Aurigene forward into building a global oncology franchise. Research Methodology The market study of the global computer-aided drug discovery market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports. Secondary Sources Include Financial reports of companies involved in the market. Whitepapers, research papers, and news blogs. Company websites and their product catalog. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models. Market Segmentation Global Computer-Aided Drug Discovery Market Research and Analysis by Type Global Computer-Aided Drug Discovery Market Research and Analysis by Therapeutic Area Global Computer-Aided Drug Discovery Market Research and Analysis by End User The Report Covers Comprehensive research methodology of the global computer-aided drug discovery market. This report also includes a detailed and extensive market overview with key analyst insights. An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations. Analysis of regional regulations and other government policies impacting the global computer-aided drug discovery market. Insights about market determinants that are stimulating the global computer-aided drug discovery market. Detailed and extensive market segments with the regional distribution of forecasted revenues. Extensive profiles and recent developments of market players.